SHENZHEN CELL VALLEY BIOPHARMACEUTICALS CO LTD

Overview

SHENZHEN CELL VALLEY BIOPHARMACEUTICALS CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering HUMAN DERIVED UMBILICAL WHARTON'S JELLY MESENCHYMAL STEM CELL EXOSOMES; HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMES; NK CELL-DERIVED EXOSOMES.

API / Drug Master Files

SHENZHEN CELL VALLEY BIOPHARMACEUTICALS CO LTD holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• NK CELL-DERIVED EXOSOMESActive2025-11-21
• HUMAN DERIVED UMBILICAL WHARTON'S JELLY MESENCHYMAL STEM CELL EXOSOMESActive2025-08-06
• HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED EXOSOMESActive2025-05-30

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHENZHEN CELL VALLEY BIOPHARMACEUTICALS CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.